RT @RheumatologyNet: Data from the COSMOS study showed that 44.4% of patients who received #guselkumab versus 19.8% of p
Tweet Content
Data from the COSMOS study showed that 44.4% of patients who received #guselkumab versus 19.8% of patients who received placebo achieved a ≥20% improvement at week 24. #psoriaticarthritis
https://t.co/S3xnFSQDaJ
Links
Improved Psoriatic Arthritis Outcomes in Phase 3b Guselkinumab Trial
https://www.rheumatologynetwork.com/view/improved-psoriatic-arthritis-outcomes-…
Show on Archive Page
On
Display in Search Results
On
PDQ
Off